{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:51:19Z","timestamp":1793670679836,"version":"4.5.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18602-0","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:22:23Z","timestamp":1762010543000},"page":"977-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating Organotrophic Risk Factors, Time to Development, and Outcomes of Solitary Brain Metastasis After Esophagectomy: A Multicenter Cohort Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Stijn","family":"Vanstraelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Gisbertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meindert","family":"Sosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Wijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Nafteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Depypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"3","key":"18602_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"18602_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/SLA.0000000000001101","volume":"262","author":"S Kumar","year":"2015","unstructured":"Kumar S, Huang J, Abbassi-Ghadi N, et al. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann Surg. 2015;262(6):981\u201390. https:\/\/doi.org\/10.1097\/SLA.0000000000001101.","journal-title":"Ann Surg"},{"issue":"12","key":"18602_CR3","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","volume":"8","author":"F Lou","year":"2013","unstructured":"Lou F, Sima CS, Adusumilli PS, et al. Esophageal cancer recurrence patterns and implications for surveillance. J Thoracic Oncol. 2013;8(12):1558\u201362. https:\/\/doi.org\/10.1097\/01.JTO.0000437420.38972.fb.","journal-title":"J Thoracic Oncol"},{"key":"18602_CR4","doi-asserted-by":"publisher","unstructured":"Vanstraelen S, Coosemans W, Depypere L, et al. Real-life introduction of powered circular stapler for esophagogastric anastomosis: cohort and propensity matched score study. Dis Esophagus. 2022;36(5):doac073. https:\/\/doi.org\/10.1093\/dote\/doac073","DOI":"10.1093\/dote\/doac073"},{"issue":"9","key":"18602_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.04.015","volume":"49","author":"S Vanstraelen","year":"2023","unstructured":"Vanstraelen S, Depypere L, Moons J, et al. How to handle brain tumors after esophagectomy with curative intent: a single center 20-year experience. European J Surg Oncol. 2023;49(9):106916. https:\/\/doi.org\/10.1016\/j.ejso.2023.04.015.","journal-title":"European J Surg Oncol"},{"issue":"2","key":"18602_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.athoracsur.2019.09.028","volume":"109","author":"TB Nobel","year":"2020","unstructured":"Nobel TB, Dave N, Eljalby M, et al. Incidence and risk factors for isolated esophageal cancer recurrence to the brain. Annals Thoracic Surgery. 2020;109(2):329\u201336. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.09.028.","journal-title":"Annals Thoracic Surgery"},{"issue":"5","key":"18602_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10120-020-01075-3","volume":"23","author":"K Harada","year":"2020","unstructured":"Harada K, Hwang H, Wang X, et al. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer. 2020;23(5):904\u201312. https:\/\/doi.org\/10.1007\/s10120-020-01075-3.","journal-title":"Gastric Cancer"},{"issue":"4","key":"18602_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/jgo.2016.03.12","volume":"7","author":"N Kothari","year":"2016","unstructured":"Kothari N, Mellon E, Hoffe SE, et al. Outcomes in patients with brain metastasis from esophageal carcinoma. J Gastrointest Oncol. 2016;7(4):562\u20139. https:\/\/doi.org\/10.21037\/jgo.2016.03.12.","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"18602_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/cncr.11737","volume":"98","author":"JS Weinberg","year":"2003","unstructured":"Weinberg JS, Suki D, Hanbali F, Cohen ZR, Lenzi R, Sawaya R. Metastasis of esophageal carcinoma to the brain. Cancer. 2003;98(9):1925\u201333. https:\/\/doi.org\/10.1002\/cncr.11737.","journal-title":"Cancer"},{"issue":"6","key":"18602_CR10","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.athoracsur.2006.06.089","volume":"82","author":"TW Rice","year":"2006","unstructured":"Rice TW, Khuntia D, Rybicki LA, et al. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Annals Thoracic Surg. 2006;82(6):2042\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.06.089.","journal-title":"Annals Thoracic Surg"},{"issue":"3","key":"18602_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jtcvs.2022.08.009","volume":"165","author":"D Chen","year":"2023","unstructured":"Chen D, Kong M, Sun J, et al. Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010. J Thoracic Cardiovasc Surg. 2023;165(3):888\u201397. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.08.009.","journal-title":"J Thoracic Cardiovasc Surg"},{"issue":"4","key":"18602_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00268-015-3334-8","volume":"40","author":"Y Hiyoshi","year":"2016","unstructured":"Hiyoshi Y, Yoshida N, Watanabe M, et al. Late recurrence after radical resection of esophageal cancer. World J Surg. 2016;40(4):913\u201320. https:\/\/doi.org\/10.1007\/s00268-015-3334-8.","journal-title":"World J Surg"},{"issue":"1","key":"18602_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/SLA.0000000000002435","volume":"269","author":"T Steffen","year":"2019","unstructured":"Steffen T, Dietrich D, Schnider A, et al. Recurrence patterns and long-term results after induction chemotherapy, chemoradiotherapy, and curative surgery in patients with locally advanced esophageal cancer. Ann Surg. 2019;269(1):83\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000002435.","journal-title":"Ann Surg"},{"issue":"1","key":"18602_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12508","volume":"30","author":"L Depypere","year":"2017","unstructured":"Depypere L, Lerut T, Moons J, et al. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road. Dis Esophagus. 2017;30(1):1\u20138. https:\/\/doi.org\/10.1111\/dote.12508.","journal-title":"Dis Esophagus"},{"issue":"12","key":"18602_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/doz034","volume":"32","author":"MFJ Seesing","year":"2019","unstructured":"Seesing MFJ, van der Veen A, Brenkman HJF, et al. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study. Dis Esophagus. 2019;32(12):1\u20138. https:\/\/doi.org\/10.1093\/dote\/doz034.","journal-title":"Dis Esophagus"},{"issue":"1","key":"18602_CR16","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, et al. Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol. 2020;21(1):e18\u201328. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1.","journal-title":"Lancet Oncol"},{"issue":"11","key":"18602_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","volume":"85","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbrouckef JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85(11):867\u201372. https:\/\/doi.org\/10.2471\/BLT.07.045120.","journal-title":"Bull World Health Organ"},{"key":"18602_CR18","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. March 10, 2023. Accessed August 11, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf"},{"issue":"3","key":"18602_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.21873\/anticanres.13259","volume":"39","author":"Y Hamai","year":"2019","unstructured":"Hamai Y, Emi M, Ibuki Y, et al. Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma. Anticancer Res. 2019;39(3):1433\u201340. https:\/\/doi.org\/10.21873\/anticanres.13259.","journal-title":"Anticancer Res"},{"issue":"6","key":"18602_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10147-016-0994-9","volume":"21","author":"N Yoshida","year":"2016","unstructured":"Yoshida N, Baba Y, Shigaki H, et al. Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma. Int J Clin Oncol. 2016;21(6):1071\u20138. https:\/\/doi.org\/10.1007\/s10147-016-0994-9.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"18602_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000354736","volume":"85","author":"R Wadhwa","year":"2013","unstructured":"Wadhwa R, Taketa T, Correa AM, et al. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology. 2013;85(4):204\u20137. https:\/\/doi.org\/10.1159\/000354736.","journal-title":"Oncology"},{"issue":"8","key":"18602_CR22","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/cncr.22565","volume":"109","author":"AM Chen","year":"2007","unstructured":"Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer. 2007;109(8):1668\u201375. https:\/\/doi.org\/10.1002\/cncr.22565.","journal-title":"Cancer"},{"issue":"3","key":"18602_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.lungcan.2004.01.025","volume":"45","author":"A Bajard","year":"2004","unstructured":"Bajard A, Westeel V, Dubiez A, et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer. 2004;45(3):317\u201323. https:\/\/doi.org\/10.1016\/j.lungcan.2004.01.025.","journal-title":"Lung Cancer"},{"issue":"1","key":"18602_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00000658-194007000-00016","volume":"112","author":"Batson Oscar","year":"1940","unstructured":"Oscar Batson. The function of the vertebral veins and their role in the spread of metasteses. Ann Surg. 1940;112(1):138\u201349.","journal-title":"Ann Surg"},{"issue":"4","key":"18602_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","volume":"392","author":"H Jens","year":"2025","unstructured":"Jens H, Thomas B, Claudia S, et al. Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N Engl J Med. 2025;392(4):323\u201335. https:\/\/doi.org\/10.1056\/NEJMoa2409408.","journal-title":"N Engl J Med"},{"key":"18602_CR26","doi-asserted-by":"publisher","unstructured":"Vanstraelen S, Van Herpe F, Dekervel J, Nafteux P. Breath- and blood-based molecular assessment for gastroesophageal cancer. ESMO Gastroint Oncol. 2025;7(C):1-11. https:\/\/doi.org\/10.1016\/j.esmogo.2025.100132","DOI":"10.1016\/j.esmogo.2025.100132"},{"issue":"1","key":"18602_CR27","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.athoracsur.2020.09.074","volume":"112","author":"L Depypere","year":"2021","unstructured":"Depypere L, De Hertogh G, Moons J, et al. Importance of lymph node response after neoadjuvant chemoradiotherapy for esophageal adenocarcinoma. Annals Thoracic Surg. 2021;112(1):1847\u201354. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.09.074.","journal-title":"Annals Thoracic Surg"},{"key":"18602_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ctro.2022.08.012","volume":"37","author":"TE Kroese","year":"2022","unstructured":"Kroese TE, Jorritsma NKN, van Laarhoven HWM, et al. Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: a nationwide population-based cohort study. Clin Transl Radiat Oncol. 2022;37:109\u201315. https:\/\/doi.org\/10.1016\/j.ctro.2022.08.012.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"18602_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2468-1253(23)00316-3","volume":"9","author":"Q Liu","year":"2024","unstructured":"Liu Q, Chen J, Lin Y, et al. Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9(1):45\u201355. https:\/\/doi.org\/10.1016\/S2468-1253(23)00316-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"18602_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","volume":"15","author":"A Burgess","year":"2015","unstructured":"Burgess A, Shah K, Hough O, Hynynen K. Focused ultrasound-mediated drug delivery through the blood\u2013brain barrier. Expert Rev Neurother. 2015;15(5):477\u201391. https:\/\/doi.org\/10.1586\/14737175.2015.1028369.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"18602_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/molecules23061289","volume":"23","author":"I Zeiadeh","year":"2018","unstructured":"Zeiadeh I, Najjar A, Karaman R. Strategies for enhancing the permeation of CNS-active drugs through the blood-brain barrier: a review. Molecules. 2018;23(6):1289. https:\/\/doi.org\/10.3390\/molecules23061289.","journal-title":"Molecules"},{"key":"18602_CR32","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga N, Kosaka N, Ono M, et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun. 2015;6:6716. https:\/\/doi.org\/10.1038\/ncomms7716.","journal-title":"Nat Commun"},{"issue":"8","key":"18602_CR33","doi-asserted-by":"publisher","first-page":"E2228083","DOI":"10.1001\/jamanetworkopen.2022.28083","volume":"5","author":"C Tsai","year":"2022","unstructured":"Tsai C, Nguyen B, Luthra A, et al. Outcomes and molecular features of brain metastasis in gastroesophageal adenocarcinoma. JAMA Netw Open. 2022;5(8):E2228083. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.28083.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"18602_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41419-021-04223-4","volume":"12","author":"Z Deng","year":"2021","unstructured":"Deng Z, Cui L, Li P, et al. Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma. Cell Death Dis. 2021;12(10):935. https:\/\/doi.org\/10.1038\/s41419-021-04223-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"18602_CR35","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/S1470-2045(20)30556-8","volume":"22","author":"AJ Morgan","year":"2021","unstructured":"Morgan AJ, Giannoudis A, Palmieri C. The genomic landscape of breast cancer brain metastases: a systematic review. Lancet Oncol. 2021;22(1):e7\u201317. https:\/\/doi.org\/10.1016\/S1470-2045(20)30556-8.","journal-title":"Lancet Oncol"},{"issue":"6","key":"18602_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/SLA.0000000000002425","volume":"268","author":"LP Depypere","year":"2018","unstructured":"Depypere LP, Moons J, Mariette C, et al. Impact of extracapsular lymph node involvement after neoadjuvant chemoradiation therapy followed by surgery in carcinoma of the esophagus: a multicenter study. Ann Surg. 2018;268(6):1000\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000002425.","journal-title":"Ann Surg"},{"key":"18602_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.xjon.2023.10.016","volume":"16","author":"CN Fick","year":"2023","unstructured":"Fick CN, Dunne EG, Lankadasari MB, et al. Genomic profiling and metastatic risk in early-stage non\u2013small cell lung cancer. JTCVS Open. 2023;16:9\u201316. https:\/\/doi.org\/10.1016\/j.xjon.2023.10.016.","journal-title":"JTCVS Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18602-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:24Z","timestamp":1767573204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18602"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18602-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stijn Vanstraelen received research support from the Belgian American Education Foundation, UZ Leuven Future Fund, and Stand up to Cancer grant (grant number 13466). Suzanne Gisbertz is a consultant for Medicaroid, Olympus, and Johnson & Johnson. Mark I. van Berge Henegouwen is proctor for Intuitive and a consultant for Medtronic, Johnson & Johnson, BBraun, and Stryker. All fees paid to their institution. Philippe Nafteux has received research support from a Stand up to Cancer grant (grant number 13466). Lieven Depypere has received research support from the UZ Leuven Research Fund. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}